Znf259 sirna sc 35282

Manufactured by Santa Cruz Biotechnology

Sourced in United States

ZNF259-siRNA (sc-35282) is a short interfering RNA (siRNA) targeting the ZNF259 gene. This product is designed for the specific knockdown of ZNF259 gene expression.

Automatically generated - may contain errors

Lab products found in correlation

Pcmv6 ddk myc, by OriGene (2 mentions) Lipofectamine 3000 reagent, by Thermo Fisher Scientific (2 mentions) Pcmv6 ddk myc znf259, by OriGene (2 mentions) Nc sirna sc 37007, by Santa Cruz Biotechnology (1 mentions)

Close spelling variants of this product

SiRNAs (95 citations)

2 protocols using znf259 sirna sc 35282

Plasmid Transfection and siRNA Silencing

Check if the same lab product or an alternative is used in the 5 most similar protocols

Plasmids pCMV6-ddk-myc and pCMV6-ddk-myc-ZNF259 were purchased from Origene (RC205721; Origene, Rockville, MD, USA). ZNF259-siRNA (sc-35282) and negative control-siRNA (sc-37007) were purchased from Santa Cruz Biotechnology. Transfection was carried out using the Lipofectamine 3000 reagent (Thermo Fisher Scientific) according to the manufacturer’s instructions. Cells were harvested within 48 h after plasmid transfection. For siRNA treatment, cells were harvested after 72 h.

Shan Y., Cao W., Wang T., Jiang G., Zhang Y, & Yang X. (2017). ZNF259 inhibits non-small cell lung cancer cells proliferation and invasion by FAK-AKT signaling. Cancer Management and Research, 9, 879-889.

+ Open protocol

+ Expand

Plasmid Transfection Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols

Plasmids pCMV6-ddk-myc and pCMV6-ddk-myc-ZNF259 were purchased from Origene (RC205721, Rockville, MD, USA). ZNF259-siRNA (sc-35282) and NC-siRNA (sc-37007) were purchased from Santa Cruz Biotechnology (Dallas, TX, USA). Transfection was carried out using the Lipofectamine 3000 reagent (Invitrogen) according to the manufacturer’s instructions.

Liu B., Xing X., Li X., Guo Q., Xu T, & Xu K. (2018). ZNF259 promotes breast cancer cells invasion and migration via ERK/GSK3β/snail signaling. Cancer Management and Research, 10, 3159-3168.

+ Open protocol

+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Revolutionizing how scientists
search and build protocols!